129 related articles for article (PubMed ID: 26410168)
1. Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression.
Zheng H; Nong Z; Lu G
Med Sci Monit; 2015 Sep; 21():2893-9. PubMed ID: 26410168
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract][Full Text] [Related]
3. Correlation between expression of NF-E2-related factor 2 and progression of gastric cancer.
Bao J; Li J; Li D; Li Z
Int J Clin Exp Med; 2015; 8(8):13235-42. PubMed ID: 26550248
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
6. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer.
Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Shirmohamadi M; Eftekhar-Sadat AT; Samadi N
Biomed Pharmacother; 2018 Jan; 97():286-292. PubMed ID: 29091877
[TBL] [Abstract][Full Text] [Related]
8. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
9. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
Guo C; Wang W; Shi Q; Chen P; Zhou C
Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer.
Hu XF; Yao J; Gao SG; Wang XS; Peng XQ; Yang YT; Feng XS
Asian Pac J Cancer Prev; 2013; 14(9):5231-5. PubMed ID: 24175806
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
[TBL] [Abstract][Full Text] [Related]
14. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
16. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
17. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
18. Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.
Yang Q; Ye Z; Zhang Q; Zhao Z; Yuan H
Tumour Biol; 2016 Jan; 37(1):1189-95. PubMed ID: 26282002
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma].
Mao JT; Tangsakar E; Shen H; Wang ZQ; Zhang MX; Chen JX; Zhang G; Wang JS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1231-3. PubMed ID: 22078454
[TBL] [Abstract][Full Text] [Related]
20. Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients.
Martinho O; Simões K; Longatto-Filho A; Jacob CE; Zilberstein B; Bresciani C; Gama-Rodrigues J; Cecconello I; Alves V; Reis RM
Oncol Rep; 2013 Feb; 29(2):690-6. PubMed ID: 23232914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
